American Herbal Products Association (AHPA) > About Us > Committees > Government Relations Committee

Government Relations Committee

Chairperson: Staci Eisner (Cortex Scientific)
Staff Contact: Michael McGuffin

Committee Purpose: To monitor legislative and regulatory issues and agencies for the purpose of developing industry positions that conform to AHPA's mission.

AHPA Members, if you would like to join this committee, please email the staff contact.

 

Committee Meeting Minutes and News

October 7, 2016 Meeting Minutes

AHPA Government Relations Committee meeting minutes

AHPA Members log in to download the meeting minutes.

AHPA submits comments to FDA on revised NDI draft guidance

Draft NDI guidance fails to achieve FDA's stated goals and is contrary to intent of the law

In comments submitted to the Food and Drug Administration (FDA), the American Herbal Products Association (AHPA) expressed concern that the latest revision of draft guidance for New Dietary Ingredients (NDIs) is unlikely to achieve FDA's stated goals and is contrary to the intent of the law in numerous areas.

AHPA submits comments to DEA on potential impacts of scheduling herbal constituents

DEA should avoid restricting research on new medical uses, health benefits, or other uses for botanicals

In comments submitted last week to the Drug Enforcement Agency (DEA), the American Herbal Products Association (AHPA) urged the agency to refrain from using its authority to effectively remove a plant from the existing marketplace because naturally occurring constituents become scheduled under the Controlled Substances Act (CSA).

AHPA submits comments to FTC regarding consumer perceptions of "organic" claims

Many personal care products and dietary supplements are produced in compliance with USDA's National Organic Progam

AHPA stressed that non-food products, including personal care products, may be agricultural products that can comply with the United States Department of Agriculture (USDA) National Organic Program (NOP).

AHPA submits vinpocetine comments to FDA

HHS Secretary has authority to create exceptions to dietary supplement definition

The American Herbal Products Association (AHPA) recommends the Secretary of Health and Human Services (HHS) consider initiating rulemaking to declare vinpocetine to be lawful dietary ingredient in comments submitted to the Food and Drug Administration (FDA).

FDA Releases Revised Draft of NDI Guidance

Revised draft replaces FDA’s 2011 draft

The Food and Drug Administration (FDA) today released revised draft guidance for new dietary ingredients (NDIs) to be published in the Federal Register on Friday. The revised draft replaces FDA’s 2011 draft.

FDA Issues Final Rule Amending Food Facility Registration Regulations

Rule effective date: September 12, 2016

On July 13, 2016, FDA issued the final rule, “Amendments to Registration of Food Facilities.” The final rule implements the food facilities registration provisions of section 415 of the Food Drug and Cosmetic Act, as amended by the Food Safety Modernization Act (FSMA); amends and updates Food and Drug Administration (FDA) registration regulations; and improves the utility of the food registration database.

AHPA Opposes Blumenthal-Durbin Amendment to Restrict Some Supplement Sales on Military Bases

AHPA opposes separate regulatory standards that differ from existing general standards

“It is illogical as a regulatory principle and unworkable from a business perspective to require one set of rules for products sold through one channel of trade, such as stores on military bases, and another set of rules in the rest of the country,” said AHPA president, Michael McGuffin.

March 11, 2016 Meeting Minutes

Government Relations Committee meeting minutes

AHPA Members log in to download the meeting minutes

Free AHPA-UNPA Webinar Prepares Members for a State Attorney General Call

Tips on how your company should respond to a state attorney general's letter of inquiry

Recorded March 24, 2016. Free to members and nonmembers.

RSS
123